ECB-ART-47326
Cancer Lett
2019 Oct 01;461:123-131. doi: 10.1016/j.canlet.2019.07.012.
Show Gene links
Show Anatomy links
Notch signaling in breast cancer: From pathway analysis to therapy.
Krishna BM
,
Jana S
,
Singhal J
,
Horne D
,
Awasthi S
,
Salgia R
,
Singhal SS
.
???displayArticle.abstract???
The Notch signaling pathway, which is highly conserved from sea urchins to humans, plays an important role in cell-differentiation, survival, proliferation, stem-cell renewal, and determining cell fate during development and morphogenesis. It is well established that signaling pathways are dysregulated in a wide-range of diseases, including human malignancies. Studies suggest that the dysregulation of the Notch pathway contributes to carcinogenesis, cancer stem cell renewal, angiogenesis, and chemo-resistance. Elevated levels of Notch receptors and ligands have been associated with cancer-progression and poor survival. Furthermore, the Notch signaling pathway regulates the transcriptional activity of key target genes through crosstalk with several other signaling pathways. Indeed, increasing evidence suggests that the Notch signaling pathway may serve as a therapeutic target for the treatment of several cancers, including breast cancer. Researchers have demonstrated the anti-tumor properties of Notch inhibitors in various cancer types. Currently, Notch inhibitors are being evaluated for anticancer efficacy in a number of clinical-trials. However, because there are multiple Notch receptors that can exhibit either oncogenic or tumor-suppressing roles in various cells, it is important that the Notch inhibitors are specific to particular receptors that are tumorigenic in nature. This review critically evaluates existing Notch inhibitory drugs and strategies and summarizes the previous discoveries, current understandings, and recent developments in support of Notch receptors as therapeutic targets in breast cancer.
???displayArticle.pubmedLink??? 31326555
???displayArticle.pmcLink??? PMC9003668
???displayArticle.link??? Cancer Lett
???displayArticle.grants??? [+]
P30 CA033572 NCI NIH HHS
Genes referenced: LOC100887844 LOC115919910
References [+] :
Al-Hajj,
Prospective identification of tumorigenic breast cancer cells.
2003, Pubmed
Al-Hajj, Prospective identification of tumorigenic breast cancer cells. 2003, Pubmed
Amsen, Notch in T Cell Differentiation: All Things Considered. 2015, Pubmed
Aste-Amézaga, Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. 2010, Pubmed
Aster, The folding and structural integrity of the first LIN-12 module of human Notch1 are calcium-dependent. 1999, Pubmed
Beel, Substrate specificity of gamma-secretase and other intramembrane proteases. 2008, Pubmed
Bi, Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G0/G1cell cycle arrest and regulation of STAT3 signalling pathway. 2018, Pubmed
Borggrefe, The Notch signaling pathway: transcriptional regulation at Notch target genes. 2009, Pubmed
Brou, A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. 2000, Pubmed
Chen, Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells. 2016, Pubmed
Croce, Evolution of the Wnt pathways. 2008, Pubmed
Dang, Notch, apoptosis and cancer. 2012, Pubmed
Deftos, Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. 2000, Pubmed
Diévart, Involvement of Notch1 in the development of mouse mammary tumors. 1999, Pubmed
Dufraine, Notch signaling regulates tumor angiogenesis by diverse mechanisms. 2008, Pubmed
Efferson, Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. 2010, Pubmed
Fleisher, Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. 2008, Pubmed
Gallahan, Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. 1987, Pubmed
Gertsik, Complex regulation of γ-secretase: from obligatory to modulatory subunits. 2014, Pubmed
Gordon, Structural basis for autoinhibition of Notch. 2007, Pubmed
Gordon, Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of Notch. 2015, Pubmed
Guo, Role of Notch and its oncogenic signaling crosstalk in breast cancer. 2011, Pubmed
Haines, Glycosylation regulates Notch signalling. 2003, Pubmed
Han, Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. 2002, Pubmed
Hansson, Aph-1 interacts at the cell surface with proteins in the active gamma-secretase complex and membrane-tethered Notch. 2005, Pubmed
Hu, Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor. 2002, Pubmed
Ju, HER2 stabilizes survivin while concomitantly down-regulating survivin gene transcription by suppressing Notch cleavage. 2013, Pubmed
Kallifatidis, Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. 2011, Pubmed
Kawahara, Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. 2009, Pubmed
Khalil, The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. 2016, Pubmed
Kontomanolis, Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis. 2014, Pubmed
Kopan, Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. 1996, Pubmed
Kopan, The canonical Notch signaling pathway: unfolding the activation mechanism. 2009, Pubmed
Kovall, Mechanistic insights into Notch receptor signaling from structural and biochemical studies. 2010, Pubmed
Krop, Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. 2012, Pubmed
Kumar, Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. 2019, Pubmed
Kurooka, Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5. 2000, Pubmed
Lardelli, Notch-related genes in animal development. 1995, Pubmed
Lee, A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex. 2004, Pubmed
Lee, Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. 2008, Pubmed
Lee, Soy and isoflavone consumption in relation to prostate cancer risk in China. 2003, Pubmed
Leong, Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. 2007, Pubmed
Li, Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. 2008, Pubmed
Lieber, Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. 1993, Pubmed
Logeat, The Notch1 receptor is cleaved constitutively by a furin-like convertase. 1998, Pubmed
Lombardo, Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. 2012, Pubmed
Luistro, Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. 2009, Pubmed
López-Schier, Drosophila nicastrin is essential for the intramembranous cleavage of notch. 2002, Pubmed
Marchal, A PEST-like sequence mediates phosphorylation and efficient ubiquitination of yeast uracil permease. 1998, Pubmed
McCubrey, Targeting breast cancer initiating cells: advances in breast cancer research and therapy. 2014, Pubmed
Meurette, Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. 2009, Pubmed
Meyer, PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. 2011, Pubmed
Micchelli, The function and regulation of cut expression on the wing margin of Drosophila: Notch, Wingless and a dominant negative role for Delta and Serrate. 1997, Pubmed
Miele, Arbiter of differentiation and death: Notch signaling meets apoptosis. 1999, Pubmed
Mittal, Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers. 2014, Pubmed
Morsut, Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors. 2016, Pubmed
Mumm, A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. 2000, Pubmed
Nagamatsu, NOTCH4 is a potential therapeutic target for triple-negative breast cancer. 2014, Pubmed
Nam, Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. 2006, Pubmed
Okajima, Chaperone activity of protein O-fucosyltransferase 1 promotes notch receptor folding. 2005, Pubmed
Osipo, ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. 2008, Pubmed
Pan, Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. 2012, Pubmed
Parr, The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. 2004, Pubmed
Pasca di Magliano, Hedgehog signalling in cancer formation and maintenance. 2003, Pubmed
Placanica, Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 gamma-secretase complexes. 2009, Pubmed
Pratt, The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptors. 2011, Pubmed
Radtke, Deficient T cell fate specification in mice with an induced inactivation of Notch1. 1999, Pubmed
Ran, γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. 2017, Pubmed
Rasul, Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. 2009, Pubmed
Rebay, Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. 1991, Pubmed
Rechsteiner, PEST sequences and regulation by proteolysis. 1996, Pubmed
Reedijk, High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. 2005, Pubmed
Ridgway, Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. 2006, Pubmed
Rizzo, Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. 2008, Pubmed
Roybal, Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits. 2016, Pubmed
Sales-Dias, The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells. 2019, Pubmed
Sanalkumar, Non-canonical activation of Notch signaling/target genes in vertebrates. 2010, Pubmed
Sanchez-Irizarry, Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. 2004, Pubmed
Sethi, Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. 2011, Pubmed
Shi, Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. 2003, Pubmed
Shih, Notch signaling, gamma-secretase inhibitors, and cancer therapy. 2007, Pubmed
Sierra, Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. 2014, Pubmed
Smith-Warner, Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. 2003, Pubmed
Souilhol, RBP-Jkappa-dependent notch signaling is dispensable for mouse early embryonic development. 2006, Pubmed
Stahl, Roles of Pofut1 and O-fucose in mammalian Notch signaling. 2008, Pubmed
Steiner, A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. 1999, Pubmed
Struhl, Nuclear access and action of notch in vivo. 1998, Pubmed
Stylianou, Aberrant activation of notch signaling in human breast cancer. 2006, Pubmed
Sugimoto, Notch2 signaling is required for potent antitumor immunity in vivo. 2010, Pubmed
Suman, Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. 2013, Pubmed
Tagami, Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. 2008, Pubmed
Themeli, New cell sources for T cell engineering and adoptive immunotherapy. 2015, Pubmed
Theodosiou, Evolutionary scenarios of Notch proteins. 2009, Pubmed
Uyttendaele, Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. 1996, Pubmed
Vinay, Immune evasion in cancer: Mechanistic basis and therapeutic strategies. 2015, Pubmed
Wallberg, p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. 2002, Pubmed
Wang, Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. 2006, Pubmed
Wang, Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. 2006, Pubmed
Wei, Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. 2010, Pubmed
Weijzen, Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. 2002, Pubmed
Weinmaster, Notch2: a second mammalian Notch gene. 1992, Pubmed
Wolfe, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. 1999, Pubmed
Wu, MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. 2000, Pubmed
Wu, Therapeutic antibody targeting of individual Notch receptors. 2010, Pubmed
Xing, Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. 2011, Pubmed
Xu, Notch Signaling during Oogenesis in Drosophila melanogaster. 2012, Pubmed
Yamamoto, Endocytosis and intracellular trafficking of Notch and its ligands. 2010, Pubmed
Yan, Delta-like 4/Notch signaling and its therapeutic implications. 2007, Pubmed
Zeng, Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. 2005, Pubmed
Zhao, Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin. 2010, Pubmed
Zhou, Dietary polyphenol quercetin targets pancreatic cancer stem cells. 2010, Pubmed
de Celis, Feed-back mechanisms affecting Notch activation at the dorsoventral boundary in the Drosophila wing. 1997, Pubmed
del Amo, Cloning, analysis, and chromosomal localization of Notch-1, a mouse homolog of Drosophila Notch. 1993, Pubmed
van Es, Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. 2005, Pubmed